ALXN

Alexion Pharmaceuticals Inc
ALXN

Overview Fund Activity
Delisted

ALXN was delisted on the 20th of July, 2021.

Back to rankings

702 hedge funds and large institutions have $22.6B invested in Alexion Pharmaceuticals Inc in 2020 Q3 according to their latest regulatory filings, with 75 funds opening new positions, 261 increasing their positions, 262 reducing their positions, and 70 closing their positions.

Holders
702
Holders Change
+2
Holders Change %
+0.29%
% of All Funds
14.2%
Holding in Top 10
18
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-14.29%
% of All Funds
0.36%
New
75
Increased
261
Reduced
262
Closed
70
Calls
$275M
Puts
$315M
Net Calls
-$40.8M
Net Calls Change
+$31.5M

Top Buyers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$2.27B
2
Janus Henderson Group
2
Janus Henderson Group
United Kingdom
$177M
3
Man Group
3
Man Group
United Kingdom
$156M
4
AL
4
AJO LP
Pennsylvania
$101M
5
Nomura Holdings
5
Nomura Holdings
Japan
$76.5M

Top Sellers

1
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$357M
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$1.12B
3
Ameriprise
3
Ameriprise
Minnesota
$584M
4
HM
4
HealthCor Management
New York
$0
5
DnB Asset Management
5
DnB Asset Management
Norway
$11.5M
Name Market Value Shares Shares
Change 		Shares
Change %
Vanguard Group
1
Vanguard Group
Pennsylvania
$2.27B 19,843,920 +2,831,898 +17%
BlackRock
2
BlackRock
New York
$2.07B 18,099,745 -428,185 -2%
State Street
3
State Street
Massachusetts
$1.27B 11,139,445 +66,854 +0.6%
Fidelity Investments
4
Fidelity Investments
Massachusetts
$1.12B 9,792,447 -3,208,004 -25%
BBA
5
Baker Bros. Advisors
New York
$1B 8,760,794 – –
ClearBridge Investments
6
ClearBridge Investments
New York
$733M 6,408,230 -491,377 -7%
Ameriprise
7
Ameriprise
Minnesota
$584M 5,100,886 -935,750 -16%
Renaissance Technologies
8
Renaissance Technologies
New York
$544M 4,757,243 +278,000 +6%
JPMorgan Chase & Co
9
JPMorgan Chase & Co
New York
$472M 4,199,711 +374,895 +10%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$433M 3,788,709 -2,410 -0.1%
LSV Asset Management
11
LSV Asset Management
Illinois
$405M 3,542,898 +43,464 +1%
Norges Bank
12
Norges Bank
Norway
$402M 3,511,156 -57,898 -2%
T. Rowe Price Associates
13
T. Rowe Price Associates
Maryland
$357M 3,115,735 -4,324,105 -58%
Northern Trust
14
Northern Trust
Illinois
$322M 2,810,217 -10,553 -0.4%
Swedbank
15
Swedbank
Sweden
$300M 2,617,594 -13,687 -0.5%
O
16
OrbiMed
New York
$250M 2,184,500 +28,500 +1%
First Trust Advisors
17
First Trust Advisors
Illinois
$245M 2,141,625 +178,489 +9%
Bank of America
18
Bank of America
North Carolina
$227M 1,985,370 +52,925 +3%
CS
19
Credit Suisse
Switzerland
$225M 1,962,156 -148,259 -7%
AQR Capital Management
20
AQR Capital Management
Connecticut
$214M 1,884,423 -223,011 -11%
PAMU
21
Pictet Asset Management (UK)
United Kingdom
$208M 1,814,047 -77,280 -4%
Manulife (Manufacturers Life Insurance)
22
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$204M 1,779,617 -33,041 -2%
Bank of New York Mellon
23
Bank of New York Mellon
New York
$203M 1,773,016 +93,861 +6%
UBS AM
24
UBS AM
Illinois
$182M 1,592,433 -60,415 -4%
Janus Henderson Group
25
Janus Henderson Group
United Kingdom
$177M 1,547,353 +1,313,698 +562%
1
2 3 4 5